Cargando…

Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy

Pathogenic variants in MYBPC3, encoding cardiac MyBP-C (myosin binding protein C), are the most common cause of familial hypertrophic cardiomyopathy. A large number of unique MYBPC3 variants and relatively small genotyped hypertrophic cardiomyopathy cohorts have precluded detailed genotype-phenotype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helms, Adam S., Thompson, Andrea D., Glazier, Amelia A., Hafeez, Neha, Kabani, Samat, Rodriguez, Juliani, Yob, Jaime M., Woolcock, Helen, Mazzarotto, Francesco, Lakdawala, Neal K., Wittekind, Samuel G., Pereira, Alexandre C., Jacoby, Daniel L., Colan, Steven D., Ashley, Euan A., Saberi, Sara, Ware, James S., Ingles, Jodie, Semsarian, Christopher, Michels, Michelle, Olivotto, Iacopo, Ho, Carolyn Y., Day, Sharlene M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676622/ https://www.ncbi.nlm.nih.gov/pubmed/32841044 http://dx.doi.org/10.1161/CIRCGEN.120.002929

Ejemplares similares

Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation
por: Thompson, Andrea D., et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry
por: Marstrand, Peter, et al.
Publicado: (2020)

Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
por: Marston, Nicholas A, et al.
Publicado: (2021)

Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry
por: Canepa, Marco, et al.
Publicado: (2020)

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
por: Ho, Carolyn Y., et al.
Publicado: (2018)

Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry
por: Abou Alaiwi, Sarah, et al.
Publicado: (2023)

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM
por: Pioner, Josè Manuel, et al.
Publicado: (2023)

Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions
por: Zhang, Xiaolei, et al.
Publicado: (2020)

Molecular autopsy in victims of inherited arrhythmias
por: Semsarian, Christopher, et al.
Publicado: (2016)

Sex‐Related Differences in Genetic Cardiomyopathies
por: Argirò, Alessia, et al.
Publicado: (2022)

Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy
por: Walsh, Roddy, et al.
Publicado: (2019)

Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation
por: Lynch, Thomas L., et al.
Publicado: (2015)

Sex Differences in Hypertrophic Cardiomyopathy: Interaction With Genetics and Environment
por: Butters, Alexandra, et al.
Publicado: (2021)

Routinely collected health data to study inherited heart disease: a systematic review (2000–2016)
por: Blanch, Bianca, et al.
Publicado: (2017)

Evaluating a custom-designed aid to improve communication of genetic results in families with hypertrophic cardiomyopathy: study protocol for a randomised controlled trial
por: Burns, Charlotte, et al.
Publicado: (2019)

Is MYBPC3 linked to bicuspid aortic valve?
por: Niaz, Talha, et al.
Publicado: (2021)

Development of a communication aid for explaining hypertrophic cardiomyopathy genetic test results
por: Smagarinsky, Yana, et al.
Publicado: (2017)

Doctor-patient care relationship in genetic cardiomyopathies: An exploratory study on clinical consultations
por: Fioretti, Chiara, et al.
Publicado: (2020)

INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy—a Randomised Intervention Trial with losartan)
por: Olivotto, Iacopo, et al.
Publicado: (2015)

Needs analysis of parents following sudden cardiac death in the young
por: McDonald, Kristie, et al.
Publicado: (2020)

Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies
por: Rani, Deepa Selvi, et al.
Publicado: (2023)

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023)

Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers
por: Sweeting, Joanna, et al.
Publicado: (2016)

MYBPC2 and MYL1 as Significant Gene Markers for Rhabdomyosarcoma
por: Chen, Zihang, et al.
Publicado: (2021)

MYBPC1 is a key regulator for laryngeal carcinoma formation
por: Liu, Jing, et al.
Publicado: (2022)

Is haploinsufficiency a sufficient mechanism for MYBPC3 truncating mutations?
por: Barefield, David Y.
Publicado: (2023)

Exome sequencing identifies a novel mutation in the MYH6 gene in a family with early-onset sinus node dysfunction, ventricular arrhythmias, and cardiac arrest()
por: Lam, Lien, et al.
Publicado: (2015)

LAMP2 shines a light on cardiomyopathy in an athlete
por: Martin, Sophie, et al.
Publicado: (2017)

Evaluation of a polymorphism in MYBPC3 in patients with anthracycline induced cardiotoxicity
por: Vinodhini, M. Thirumalai, et al.
Publicado: (2018)

An interesting Mybpc3 heterozygous mutation associated with bicuspid aortic valve
por: Zhao, Xiaopei, et al.
Publicado: (2020)

Sarcomeric deficits underlie MYBPC1-associated myopathy with myogenic tremor
por: Geist Hauserman, Janelle, et al.
Publicado: (2021)

MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis
por: Zou, Xiaodong, et al.
Publicado: (2022)

Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

An Unbiased Screen Identified the Hsp70-BAG3 Complex as a Regulator of Myosin-Binding Protein C3
por: Thompson, Andrea D., et al.
Publicado: (2023)

Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy
por: Toepfer, Christopher N., et al.
Publicado: (2020)

Rare desmin variant causing penetrant life-threatening arrhythmic cardiomyopathy
por: Oomen, Ad W.G.J., et al.
Publicado: (2018)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene
por: Ehlermann, Philipp, et al.
Publicado: (2008)

Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3
por: Aurensanz Clemente, Esther, et al.
Publicado: (2017)

Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy
por: Suay-Corredera, Carmen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4b3sq33etge273lideqgb9shrn